Latest News
July 12, 2016
Private Investment Group Leads $10 Million B Funding Round In Immunarray
Exigent announces investment in molecular diagnostic company during visit by Virginia Governor Terry McAuliffe to Jerusalem.
January 23, 2014
$300,000 GE NFL Head Health Challenge Grant Will Fund Research Based On Johns Hopkins-Licensed Patents Connecting Protein Markers In Blood And Acute Brain Injury
ImmunArray, the Richmond, Va. and Rehovot, Israel-based developer of a breakthrough chip-based technology with the capacity to detect the presence of…
January 23, 2013
Immunarray Ltd Announces The Licensing Of A Portfolio Of Novel Proteins For The Diagnosis And Monitoring Of Therapy Across A Range Of Disorders Involving Acute Brain Injury
ImmunArray, developer of the iCHIP™, a groundbreaking in-vitro auto-antibody detection technology, is pleased to announce the license and onset of development…
Publications
Nothing found.